J Liang1,2, F Yu2, J Zhu2, T Song1. 1. School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China. 2. State Key Laboratory of Oncology in South China//Department of Radiotherapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Abstract
OBJECTIVE: To investigate the influence of positioning accuracy of the multi-leaf collimators (MLC) on the passing rate of the plan dose verification for volumetric modulation arc therapy (VMAT) of cervical cancer using an Elekta linear accelerator. METHODS: The dose distributions were measured using Sun Nuclear's Mapcheck and Arccheck semiconductors matrix before and after MLC calibration in30 cervical cancer patients undergoing VMAT. Dosimetric comparisons were performed with 2D and 3D gamma passing rates of 3%, 3 mm and 2%, and 2 mm. The 3D gamma distribution was reconstructed with respect to the patient's anatomy using 3DVH software to evaluate the possible influence of MLC positioning accuracy. RESULTS: Before and after MLC calibration, the gamma passing rates of Mapcheck were (88.80±1.81)% and (99.25 ± 0.53)% under 3% and 3 mm standard, respectively, with an average increase of 10.45%. The corresponding gamma passing rates of Arccheck were (87.61±1.98)% and (98.13±0.99)%, respectively, with an average increase of 10.52%. The gamma passing rates of 3DVH were (89.87±2.28)% and (98.3±1.15)%, respectively, with an average increase of 8.43%. CONCLUSION: The MLC positioning accuracy is one of the main factors influencing dosimetric accuracy of VMAT for cervical cancer. The application of Autocal software facilitates MLC calibration and improves the accuracy and safety of VMAT delivery for cervical cancer.
OBJECTIVE: To investigate the influence of positioning accuracy of the multi-leaf collimators (MLC) on the passing rate of the plan dose verification for volumetric modulation arc therapy (VMAT) of cervical cancer using an Elekta linear accelerator. METHODS: The dose distributions were measured using Sun Nuclear's Mapcheck and Arccheck semiconductors matrix before and after MLC calibration in30 cervical cancer patients undergoing VMAT. Dosimetric comparisons were performed with 2D and 3D gamma passing rates of 3%, 3 mm and 2%, and 2 mm. The 3D gamma distribution was reconstructed with respect to the patient's anatomy using 3DVH software to evaluate the possible influence of MLC positioning accuracy. RESULTS: Before and after MLC calibration, the gamma passing rates of Mapcheck were (88.80±1.81)% and (99.25 ± 0.53)% under 3% and 3 mm standard, respectively, with an average increase of 10.45%. The corresponding gamma passing rates of Arccheck were (87.61±1.98)% and (98.13±0.99)%, respectively, with an average increase of 10.52%. The gamma passing rates of 3DVH were (89.87±2.28)% and (98.3±1.15)%, respectively, with an average increase of 8.43%. CONCLUSION: The MLC positioning accuracy is one of the main factors influencing dosimetric accuracy of VMAT for cervical cancer. The application of Autocal software facilitates MLC calibration and improves the accuracy and safety of VMAT delivery for cervical cancer.
Authors: Dan Nguyen; Daniel O'Connor; Victoria Y Yu; Dan Ruan; Minsong Cao; Daniel A Low; Ke Sheng Journal: Med Phys Date: 2015-04 Impact factor: 4.071
Authors: Miguel Jiménez-Melguizo; Miguel Espinosa; Joaquín Montes; Damián Guirado; Antonio M Lallena Journal: Phys Med Date: 2020-12-10 Impact factor: 2.685
Authors: Benjamin E Nelms; Daniel Opp; Joshua Robinson; Theresa K Wolf; Geoffrey Zhang; Eduardo Moros; Vladimir Feygelman Journal: Med Phys Date: 2012-07 Impact factor: 4.071
Authors: Kiley B Pulliam; Jessie Y Huang; Rebecca M Howell; David Followill; Ryan Bosca; Jennifer O'Daniel; Stephen F Kry Journal: Med Phys Date: 2014-02 Impact factor: 4.071
Authors: Stephanie Alimena; David D Yang; Alexander Melamed; Brandon A Mahal; Michael J Worley; Sarah Feldman; Kevin M Elias; Peter F Orio; Larissa J Lee; Martin King Journal: Gynecol Oncol Date: 2019-07-07 Impact factor: 5.482